The rising interest in effective weight management has resulted in considerable research into groundbreaking treatments. Recently , Retatrutide, a dual -action GIP and glucagon-like peptide-1 (GLP-1) receptor activator , has demonstrated positive results in clinical trials, suggesting potential for considerable weight loss . Therefore, numerous ind